亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南中科一通化工有限公司  

格列本脲,鹽酸吡格列酮、格列美脲、馬來酸羅格列酮、甲鈷胺、氯沙坦鉀、2,3,4,6-四芐基-D-吡喃葡萄糖、多潘立酮

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李曉翔
  • 電話:053188658009
  • 傳真:053188956078
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 鹽酸吡格列酮
鹽酸吡格列酮
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
型號 112529-15-4
規格 企標
過期 長期有效
更新 2011-08-15 08:54
 
詳細信息
中文名:鹽酸吡格列酮
英文名:Pioglitazone Hydrochloride
中文化學名:(±)5-[[4-[2-(5-乙基-2-吡啶基)乙氧基]苯基]甲基]-2,4-噻唑二酮鹽酸鹽

分子式:C19H20N2O3S.HCl
分子量:392.90
CAS: 112529-15-4
結構式:
           鹽酸吡格列酮, 5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮鹽酸鹽, CAS #: 112529-15-4
         
用途:新治療II型糖尿病藥。
質量標準:國家醫藥標準
項目
部標
性狀
白色結晶粉末
有關物質
≤1.0%
干燥失重
≤0.5%
熾灼殘渣
≤0.2%
重金屬
≤0.001%
含量
≥99.0%
包裝:1-25公斤/桶。
©2025 濟南中科一通化工有限公司 版權所有   技術支持:化工網   訪問量:10205  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |